Newer indications of tranexamic acid in dermatology beyond melasma: a review

Tranexamic acid (TXA) is an antifibrinolytic agent approved for use to control bleeding during surgery and after trauma. It has been used in dermatology as a therapeutic and prophylactic agent in angioedema since 1970s but its recently discovered role in melasma has made it the current molecule of interest. At present TXA is being widely researched for multiple indications in view of its role in reducing melanogenesis and angiogenesis in skin. Various case reports and clinical trials have been published over the last few years describing its role in postinflammatory hyperpigmentation, dermal melanosis, rosacea, telangiectasia, and even as an antiaging agent. We present this review here summarizing the various publications for the aforementioned indications.

[1]  A. Goodarzi,et al.  Comparison of the efficacy and safety of intralesional injection of tranexamic acid and the topical application of Kligman combination drug in the treatment of macular amyloidosis , 2021, Dermatologic therapy.

[2]  M. Elmasry,et al.  Tranexamic acid versus fractional carbon dioxide laser in post‐acne hyperpigmentation , 2021, Dermatologic therapy.

[3]  N. Litaiem,et al.  Intradermal tranexamic acid microinjections: a novel treatment option for erythematotelangiectatic rosacea , 2021, Journal of cosmetic dermatology.

[4]  Won-Serk Kim,et al.  Effect of Tranexamic Acid Administration on Postoperative Ecchymosis and Edema in Excision of Lipomas. , 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[5]  Aleksandra L. Lindgren,et al.  The Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation. , 2021, Journal of drugs in dermatology : JDD.

[6]  Tingting Zhu,et al.  Targeting delivery and minimizing epidermal diffusion of tranexamic acid by hyaluronic acid-coated liposome nanogels for topical hyperpigmentation treatment , 2021, Drug delivery.

[7]  E. Wołowiec-Korecka,et al.  The influence of topical 5% tranexamic acid at pH 2.38 with and without corundum microdermabrasion on pigmentation and skin surface lipids , 2020, Dermatologic therapy.

[8]  S. Yadav,et al.  Topical 10% Tranexamic Acid for Recalcitrant Topical Steroid-Dependent Face , 2020, Indian dermatology online journal.

[9]  R. Robati,et al.  Efficacy and safety of fractional CO2 laser and tranexamic acid versus microneedling and tranexamic acid in the treatment of infraorbital hyperpigmentation , 2020, The Journal of dermatological treatment.

[10]  S. Chiheb,et al.  Acide tranexamique oral dans le traitement du lichen pigmentogène , 2020 .

[11]  K. Sayed,et al.  Q‐Switched Nd:YAG (532 nm) Laser Versus Intra‐Dermal Tranexamic Acid for Treatment of Facial Ephelides: A Split Face, Randomized, Comparative Trial , 2020, Lasers in surgery and medicine.

[12]  D. Jakhar,et al.  Topical 5% Tranexamic acid for acne-related post inflammatory erythema. , 2020, Journal of the American Academy of Dermatology.

[13]  D. Jakhar,et al.  Topical 10% Tranexamic acid for erythematotelangiectatic steriod induced rosacea. , 2020, Journal of the American Academy of Dermatology.

[14]  Jian-wei Zhu,et al.  Activation of VEGF receptors in response to UVB promotes cell proliferation and melanogenesis of normal human melanocytes. , 2019, Experimental cell research.

[15]  O. Spigset,et al.  Cytotoxicity and effect on wound re‐epithelialization after topical administration of tranexamic acid , 2019, BJS open.

[16]  E. Ayhan.  Intralesional tranexamic acid in treatment of telangiectasia: reversible effect and resistance to therapy , 2019, Clinical and experimental dermatology.

[17]  D. Visentin,et al.  Subcutaneous Injection of Tranexamic Acid to Reduce Bleeding During Dermatologic Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. , 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[18]  Megan C. Manco,et al.  Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation , 2019, Journal of drugs in dermatology : JDD.

[19]  Ben Wang,et al.  Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis. , 2019, International immunopharmacology.

[20]  J. Na,et al.  The increase of interfollicular epidermal stem cells and regulation of aryl hydrocarbon receptor and its repressors in the skin through hydroporation with anti‐aging cocktail , 2018, Journal of cosmetic dermatology.

[21]  Zhongyi Xu,et al.  A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl’s melanosis , 2018, Journal of Cosmetic Dermatology.

[22]  G. Kontochristopoulos,et al.  The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea , 2018, Journal of cosmetic dermatology.

[23]  P. Sirithanabadeekul,et al.  Intradermal tranexamic acid injections to prevent post-inflammatory hyperpigmentation after solar lentigo removal with a Q-switched 532-nm Nd:YAG laser , 2018, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[24]  H. Longhurst,et al.  Prophylactic Therapy for Hereditary Angioedema. , 2017, Immunology and allergy clinics of North America.

[25]  J. Bae,et al.  Assessment of the efficacy and safety of a new complex skin cream in Asian women: A controlled clinical trial , 2017, Journal of cosmetic dermatology.

[26]  B. Kim,et al.  Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea , 2017, Dermatologic therapy.

[27]  Gyeong-Hun Park,et al.  A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl’s Melanosis , 2017, The Journal of dermatological treatment.

[28]  Sindy Hu,et al.  Skin Pretreatment With Conventional Non-Fractional Ablative Lasers Promote the Transdermal Delivery of Tranexamic Acid , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[29]  J. Na,et al.  Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper–GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation) , 2016, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[30]  K. Hiramoto,et al.  The amelioration effect of tranexamic acid in wrinkles induced by skin dryness. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[31]  D. Yu,et al.  Combination treatment of low-fluence Q-switched Nd:YAG laser and oral tranexamic acid for post-inflammatory hyperpigmentation due to allergic contact dermatitis to henna hair dye , 2016, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[32]  K. Hiramoto,et al.  Tranexamic acid suppresses ultraviolet B eye irradiation‐induced melanocyte activation by decreasing the levels of prohormone convertase 2 and alpha‐melanocyte‐stimulating hormone , 2014, Photodermatology, photoimmunology & photomedicine.

[33]  S. Chang,et al.  Tranexamic acid solution soaking is an excellent approach for rosacea patients: A preliminary observation in six patients , 2013, The Journal of dermatology.

[34]  M. David,et al.  Bleeding in Congenital Hemangiomas: Crusting as a Clinical Predictive Sign and Usefulness of Tranexamic Acid , 2012, Pediatric dermatology.

[35]  Ian W. Roberts.  Tranexamic Acid: a recipe for saving lives in traumatic bleeding. , 2011, The international journal of occupational and environmental medicine.

[36]  K. Yoshimura,et al.  A Prospective Randomized Controlled Study of Oral Tranexamic Acid for Preventing Postinflammatory Hyperpigmentation After Q‐Switched Ruby Laser , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[37]  Mi-Yeon Kim,et al.  Localized Intradermal Microinjection of Tranexamic Acid for Treatment of Melasma in Asian Patients: A Preliminary Clinical Trial , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[38]  K. Maeda,et al.  Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. , 1998, Journal of photochemistry and photobiology. B, Biology.

[39]  V. Vachiramon,et al.  Lasers in Surgery and Medicine , 2019 .

[40]  D. Creamer,et al.  Controlling oral haemorrhage in Steven Johnson syndrome/ Toxic Epidermal Necrolysis. , 2019, Journal of the American Academy of Dermatology.

[41]  S. Okamoto,et al.  AMINO-METHYL-CYCLOHEXANE-CARBOXYLIC ACID: AMCHA , 1962 .